(R)-1-(2-Bromopyridin-4-yl)ethanamine dihydrochloride, 97.0%, 250mg

5-Oxo-[1,4]diazepane-1-carboxylic acid tert-butylester, 97.0%, 25g

2,4-Dibromo-6-nitrophenol, 95.0%, 1g

N-[1-(4-fluorophenyl)ethyl]-N-methylamine, 95.0%, 10g

3,5-dimethyl-3'-piperidinomethyl benzophenone, 97.0%, 1g

2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid, 98.0%, 100g

4-Thiouridine>95.0%(qNMR)100mg

2-Ethoxyaniline hydrochloride, 97%, 100g

Dapoxetine hydrochloride, 95.0%, 25g

tert-butyl 3-{[3-(dimethylamino)-2,2-dimethylpropyl]amino}propanoate, 95.0%, 10g

4,4'-(Benzo[c][1,2,5]thiadiazole-4,7-diyl)dianiline, 98%, 1g

(2E)-3-(2-methoxyphenyl)-1-(2-methylphenyl)prop-2-en-1-one, 95.0%, 2g

1-Chloroadamantane, min. 98%, for synthesis, 5 g, glass packaging